MAG
JNJ icon

Meadowbrook Advisors Group’s Johnson & Johnson JNJ Stock Holding History

Meadowbrook Advisors Group’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.71M Sell
6,744
-354
-5% -$82.5K 0.92% 32
2026
Q1 		$1.74M Sell
7,098
-453
-6% -$106K 1.03% 38
2025
Q4 		$1.56M Buy
+7,551
New +$1.49M 0.88% 41

Other funds holding JNJ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Meadowbrook Advisors Group's JNJ Position: Q2 2026 in Review

Meadowbrook Advisors Group reduced its Johnson & Johnson (JNJ) stake by 5% in Q2 2026, selling an estimated $82.5K and leaving 6,744 shares worth $1.71M. The position accounts for 0.92% of the portfolio, ranked #32.

Meadowbrook Advisors Group first reported a position in JNJ in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.74M in Q1 2026. 4,655 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Meadowbrook Advisors Group held 6,744 shares of Johnson & Johnson worth $1.71M as of Q2 2026.
  • Meadowbrook Advisors Group sold 354 Johnson & Johnson shares in Q2 2026, an estimated $82.5K.
  • Johnson & Johnson made up 0.92% of Meadowbrook Advisors Group's portfolio in Q2 2026, its #32 holding.
  • Meadowbrook Advisors Group first reported a position in Johnson & Johnson in Q4 2025 and has held it in 3 quarters since.
  • Meadowbrook Advisors Group's Johnson & Johnson position peaked at $1.74M in Q1 2026.
  • 4,655 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Meadowbrook Advisors Group's 13F filing for Q2 2026, filed 7 Aug 2026.